125 related articles for article (PubMed ID: 25249426)
1. Genetic profiling of thymic carcinoma using targeted next-generation sequencing.
Shitara M; Okuda K; Suzuki A; Tatematsu T; Hikosaka Y; Moriyama S; Sasaki H; Fujii Y; Yano M
Lung Cancer; 2014 Nov; 86(2):174-9. PubMed ID: 25249426
[TBL] [Abstract][Full Text] [Related]
2. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
3. Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.
Sakane T; Sakamoto Y; Masaki A; Murase T; Okuda K; Nakanishi R; Inagaki H
Clin Lung Cancer; 2021 Mar; 22(2):92-99.e4. PubMed ID: 33414055
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.
Asao T; Fujiwara Y; Sunami K; Kitahara S; Goto Y; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Ichikawa H; Kohno T; Tsuta K; Watanabe S; Takahashi K; Ohe Y
Lung Cancer; 2016 Mar; 93():77-81. PubMed ID: 26898618
[TBL] [Abstract][Full Text] [Related]
5. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing.
Hagemann IS; Govindan R; Javidan-Nejad C; Pfeifer JD; Cottrell CE
J Thorac Oncol; 2014 Feb; 9(2):e12-6. PubMed ID: 24419427
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication.
Hu Z; Wang J; Yao T; Hong RL; Zhang K; Gao H; Wu X; Li J; Bai C; Yen Y
Lung Cancer; 2013 Jul; 81(1):27-31. PubMed ID: 23639785
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
9. Thymic carcinoma. Five distinctive histological variants.
Snover DC; Levine GD; Rosai J
Am J Surg Pathol; 1982 Jul; 6(5):451-70. PubMed ID: 7125053
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib efficacy in thymic carcinomas seems not to require c-KIT or PDGFR-alpha mutations.
Pagano M; Sierra NM; Panebianco M; Rossi G; Gnoni R; Bisagni G; Boni C
Anticancer Res; 2014 Sep; 34(9):5105-10. PubMed ID: 25202099
[TBL] [Abstract][Full Text] [Related]
11. Mutations of epigenetic regulatory genes are common in thymic carcinomas.
Wang Y; Thomas A; Lau C; Rajan A; Zhu Y; Killian JK; Petrini I; Pham T; Morrow B; Zhong X; Meltzer PS; Giaccone G
Sci Rep; 2014 Dec; 4():7336. PubMed ID: 25482724
[TBL] [Abstract][Full Text] [Related]
12. Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroid.
Pan Y; Zhao X; Yang J; Deng J; Zhan Z; Luo Y; Li Q; Guo Y; Zhai Q; Sun B
Hum Pathol; 2012 Mar; 43(3):350-5. PubMed ID: 21835435
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after surgical resection of thymic carcinoma: A study from a single tertiary referral centre.
Song Z; Zhang Y
Eur J Surg Oncol; 2014 Nov; 40(11):1523-7. PubMed ID: 24953416
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases.
Zhao Y; Zhao H; Hu D; Fan L; Shi J; Fang W
Ann Thorac Surg; 2013 Sep; 96(3):1019-24. PubMed ID: 23866799
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
[TBL] [Abstract][Full Text] [Related]
16. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
Lu H; Yang S; Zhu H; Tong X; Xie F; Qin J; Han N; Wu X; Fan Y; Shao YW; Mao W
BMC Cancer; 2018 Mar; 18(1):251. PubMed ID: 29506494
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
[TBL] [Abstract][Full Text] [Related]
18. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
[TBL] [Abstract][Full Text] [Related]
20. Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing.
Ricordel C; Lespagnol A; Llamas-Gutierrez F; de Tayrac M; Kerjouan M; Fievet A; Hamdi-Rozé H; Aliouat A; Desrues B; Mosser J; Léna H
Clin Lung Cancer; 2018 Mar; 19(2):163-169.e4. PubMed ID: 29129434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
